Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

John D. Sheppard, MD, (ophthalmologist): A diagnostic hurdle for geographic atrophy is provider awareness. What’s key is making the diagnosis prior to loss of fixation in the more severely ...

Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight-robbing condition that accompanies age-related macular degeneration (AMD ...

Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness.

These quiz questions about geographic atrophy (GA) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

Unless you’ve already been diagnosed with geographic atrophy , there’s a good chance you’ve never heard of it. And yet, the ...

Adyanthaya, MD: Most patients with an initial diagnosis of geographic atrophy should be referred to a retina specialist to see if they are candidates for treatment. On fundus examination ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related macular degeneration (AMD), a leading cause of blindness. While there are multiple therapies available for ...

The companies have successfully executed all milestones to date. About Geographic Atrophy (GA) GA is a chronic, progressive and irreversible retinal disease that occurs in people with late-stage ...

a multifunctional modifier gene therapy for the treatment of geographic atrophy or GA secondary to dry age-related macular degeneration or dAMD. The Phase 2 trial enrolled 51 subjects who were ...